Content area

|
|

Individualiseret behandling af patienter med bronkiektasier

Forfatter(e)
Ole Hilberg1, Charlotte Hyldgaard2, Anders Løkke2, Charlotte Andersen3 & Peter Lange4
1) Medicinsk Afdeling, Sygehus Lillebælt, Vejle. 2) Lungemedicinsk Afdeling, Aarhus Universitetshospital. 3) Klinisk Farmakologisk Afdeling, Aarhus Universitetshospital. 4) Hjerte-lungemedicinsk afdeling 0, Herlev Hospital

Ugeskr Læger 2018;180:V02180104
Reference: 
Ugeskr Læger 2018;180:V02180104
Blad nummer: 

Ole Hilberg, Charlotte Hyldgaard, Anders Løkke,
Charlotte Andersen & Peter Lange:

Individualised treatment of patients with bronchoectasis

Ugeskr Læger 2018;180:V02180104

Bronchiectasis is characterised by chronic cough, airway inflammation, infection and bronchial dilatation. The disease may lead to impaired lung function and premature death.
An underlying inflammatory disease or immunodeficiency may be present, but 40% of the cases are idiopathic. The diagnosis is based on high resolution CT scan. Treatment is aimed at reducing symptoms and risk of exacerbations,
and includes antibiotics, bronchodilators and pulmonary rehabilitation. Assessment of disease severity and individual phenotypes may help to modify treatment strategies in the future.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Anette Bygum | 19/05
10 kommentarer
af Hans-Iver G. F.-D Kley | 18/05
1 Kommentar
af Per Bonding | 17/05
1 Kommentar
af Jakob Ramlau | 15/05
1 Kommentar
af Svend Erik Heiselberg | 12/05
1 Kommentar